Estradiol Valerate Affects Hematological and Hemorheological Parameters in Rats

Polycystic ovary syndrome (PCOS) is one of the most common endocrinological diseases in women. Although the risk of cardiovascular diseases is high in PCOS, the number of scientific publications describing hemorheological changes is not significant. We aimed to perform a comprehensive hematological and micro-rheological study on experimentally induced PCOS in rats.Wistar rats were divided into control (n = 9) and PCOS groups (n = 9), in which animals received single-dose estradiol valerate. Measurements were carried out before treatment and monthly for four months. Bodyweight, blood glucose concentration, hematological parameters, red blood cell (RBC) deformability, and aggregation were measured. A histological examination of the ovary was performed at the end of the experiment. The blood glucose level and the bodyweight were significantly elevated vs. base in the PCOS group. A significant decrease was seen in RBC count, hemoglobin, and hematocrit. The maximal elongation index showed a significant increase. PCOS also resulted in a significant increase in RBC aggregation index parameters. The histological and hormone examinations confirmed developed PCOS. The administration of estradiol valerate caused significant changes during the examined period in hematological and hemorheological parameters. Our results draw attention to the possible usefulness of micro-rheological investigations in further studies on PCOS.

[1]  J. Brun,et al.  Metabolic Influences Modulating Erythrocyte Deformability and Eryptosis , 2021, Metabolites.

[2]  X. Yang,et al.  Profile of Bile Acid Metabolomics in the Follicular Fluid of PCOS Patients , 2021, Metabolites.

[3]  Muhammad Kamran Khan,et al.  Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model , 2020, Journal of translational medicine.

[4]  A. Ajayi,et al.  Staging of the estrous cycle and induction of estrus in experimental rodents: an update , 2020, Fertility Research and Practice.

[5]  E. Michos,et al.  Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. , 2020, Trends in cardiovascular medicine.

[6]  A. Iwase,et al.  Animal models of polycystic ovary syndrome: A review of hormone‐induced rodent models focused on hypothalamus‐pituitary‐ovary axis and neuropeptides , 2018, Reproductive medicine and biology.

[7]  Seema Patel.  Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  Rong Li,et al.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome , 2018, Fertility and sterility.

[9]  Zsuzsanna Magyar,et al.  Age- and gender-related hemorheological alterations in intestinal ischemia-reperfusion in the rat. , 2018, The Journal of surgical research.

[10]  Hongwei Wang,et al.  DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway , 2018, Journal of Ovarian Research.

[11]  N. Németh,et al.  Effects of aging and gender on micro-rheology of blood in 3 to 18 months old male and female Wistar (Crl:WI) rats. , 2018, Biorheology.

[12]  F. Tehrani,et al.  Hormone‐induced rat model of polycystic ovary syndrome: A systematic review , 2017, Life sciences.

[13]  M. Nabiuni,et al.  Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats , 2017, Cell journal.

[14]  P. Spritzer,et al.  Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review , 2017, Reproductive Biology and Endocrinology.

[15]  B. Balaji,et al.  Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism , 2016, Pharmaceutical biology.

[16]  G. Mirabolghasemi,et al.  Changes of The Uterine Tissue in Rats with Polycystic Ovary Syndrome Induced by Estradiol Valerate , 2016, International journal of fertility & sterility.

[17]  P. Madej,et al.  Thyroid disorders in polycystic ovary syndrome. , 2017, European review for medical and pharmacological sciences.

[18]  S. Sabapathy,et al.  Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary Syndrome , 2016, PloS one.

[19]  B. Larijani,et al.  Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome , 2016, EXCLI journal.

[20]  R. Granese,et al.  Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols , 2016, International journal of endocrinology.

[21]  L. Lenghel,et al.  Letrozole vs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment. , 2016, Reproduction.

[22]  Liying Yan,et al.  High-fat diets exaggerate endocrine and metabolic phenotypes in a rat model of DHEA-induced PCOS. , 2016, Reproduction.

[23]  O. Triolo,et al.  Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives , 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[24]  I. Tessaro,et al.  Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome , 2015, Journal of Ovarian Research.

[25]  Xueyong Shen,et al.  Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model , 2015, BioMed research international.

[26]  L. Kooistra,et al.  Vaginal Cytology of the Laboratory Rat and Mouse , 2015, Toxicologic pathology.

[27]  Lirong Teng,et al.  Studies on the Antidiabetic Activities of Cordyceps militaris Extract in Diet-Streptozotocin-Induced Diabetic Sprague-Dawley Rats , 2014, BioMed research international.

[28]  I. Anaforoglu,et al.  High plasma viscosity may be a predictor of cardiovascular risk in women with polycystic ovary syndrome , 2014 .

[29]  Z. Benyó,et al.  Effects of vitamin D_3 derivative — calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model , 2013, Pharmacological reports : PR.

[30]  D. Vine,et al.  Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. , 2012, Fertility and sterility.

[31]  P. Hamar,et al.  Arteriolar insulin resistance in a rat model of polycystic ovary syndrome. , 2012, Fertility and sterility.

[32]  Zsuzsanna Magyar,et al.  Following-up hemorheological consequences of gonadectomy in male and female rats. , 2012, Clinical hemorheology and microcirculation.

[33]  N. Németh,et al.  Gender differences of blood rheological parameters in laboratory animals. , 2010, Clinical hemorheology and microcirculation.

[34]  F. Broekmans,et al.  Ovarian aging: mechanisms and clinical consequences. , 2009, Endocrine reviews.

[35]  O. Baskurt,et al.  Parameterization of red blood cell elongation index – shear stress curves obtained by ektacytometry , 2009, Scandinavian journal of clinical and laboratory investigation.

[36]  G. Adonakis,et al.  Obesity and insulin resistance increase plasma viscosity in young women with polycystic ovary syndrome , 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[37]  R. Akhigbe,et al.  Hemorheological Effects of Long-Term Administration of Combined Oral Contraceptive in Rats , 2008 .

[38]  B. Pehlivanoğlu,et al.  Effect of stress on erythrocyte deformability, influence of gender and menstrual cycle. , 2007, Clinical hemorheology and microcirculation.

[39]  K. Toth,et al.  Gender differences in hemorheological parameters of coronary artery disease patients. , 2006, Clinical hemorheology and microcirculation.

[40]  Kenichi Tanaka,et al.  Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome. , 2005, Fertility and sterility.

[41]  E. Stener-Victorin,et al.  Reproductive Biology and Endocrinology Open Access Rats with Steroid-induced Polycystic Ovaries Develop Hypertension and Increased Sympathetic Nervous System Activity , 2022 .

[42]  H. Kafalı,et al.  Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. , 2004, Archives of medical research.

[43]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[44]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[45]  G. M. Goni,et al.  Effect of hormone replacement therapy upon haemorheological variables. , 2003, Clinical hemorheology and microcirculation.

[46]  J. Brun.  Hormones, metabolism and body composition as major determinants of blood rheology: potential pathophysiological meaning. , 2002, Clinical hemorheology and microcirculation.

[47]  V. Miller,et al.  Selected contribution: Effects of sex and ovariectomy on responses to platelets in porcine femoral veins. , 2001, Journal of applied physiology.

[48]  P. Lapolt,et al.  Influences of Age and Ovarian Follicular Reserve on Estrous Cycle Patterns, Ovulation, and Hormone Secretion in the Long-Evans Rat1 , 2001, Biology of reproduction.

[49]  S. Ojeda,et al.  An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. , 2000, Endocrinology.

[50]  E. Vittinghoff,et al.  Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study , 2000, Annals of Internal Medicine.

[51]  H S Borovetz,et al.  Gender difference in rheologic properties of blood and risk of cardiovascular diseases. , 1999, Clinical hemorheology and microcirculation.

[52]  R. Guillet,et al.  Gender, menstrual cycle, oral contraceptives and red blood cell deformability in healthy adult subjects. , 1998, Clinical hemorheology and microcirculation.

[53]  S. Ojeda,et al.  Activation of ovarian sympathetic nerves in polycystic ovary syndrome. , 1993, Endocrinology.

[54]  P. Valensi,et al.  Glucagon and noradrenaline reduce erythrocyte deformability. , 1993, Metabolism: clinical and experimental.

[55]  Vera Baumans,et al.  Principles of laboratory animal science : a contribution to the humane use and care of animals and to the quality of experimental results , 1993 .